COMMERZBANK AG (CBK.DE)

DE000CBK1001 - Common Stock

13.88  +0.38 (+2.78%)

Fundamental Rating

4

Taking everything into account, CBK scores 4 out of 10 in our fundamental rating. CBK was compared to 92 industry peers in the Banks industry. Both the profitability and financial health of CBK have multiple concerns. A decent growth rate in combination with a cheap valuation! Better keep an eye on CBK.



2

1. Profitability

1.1 Basic Checks

CBK had positive earnings in the past year.
CBK had a positive operating cash flow in the past year.
CBK had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CBK reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.39%, CBK is doing worse than 75.00% of the companies in the same industry.
CBK's Return On Equity of 6.35% is on the low side compared to the rest of the industry. CBK is outperformed by 60.23% of its industry peers.
Industry RankSector Rank
ROA 0.39%
ROE 6.35%
ROIC N/A
ROA(3y)0.24%
ROA(5y)0.05%
ROE(3y)3.83%
ROE(5y)0.57%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CBK has a Profit Margin of 16.15%. This is in the lower half of the industry: CBK underperforms 77.27% of its industry peers.
In the last couple of years the Profit Margin of CBK has grown nicely.
CBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 16.15%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y10.91%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBK has been reduced compared to 1 year ago.
Compared to 5 years ago, CBK has less shares outstanding
Compared to 1 year ago, CBK has a worse debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of CBK is 2.53, which is a good value as it means it would take CBK, 2.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.53, CBK belongs to the top of the industry, outperforming 92.05% of the companies in the same industry.
CBK has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.51, CBK is in line with its industry, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 2.53
Altman-Z N/A
ROIC/WACCN/A
WACC3.12%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.98% over the past year.
The Earnings Per Share has been growing by 21.39% on average over the past years. This is a very strong growth
CBK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.75%.
CBK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.93% yearly.
EPS 1Y (TTM)73.98%
EPS 3YN/A
EPS 5Y21.39%
EPS growth Q2Q-21.95%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y10.75%
Revenue growth 5Y6.93%
Revenue growth Q2Q9.1%

3.2 Future

Based on estimates for the next years, CBK will show a very strong growth in Earnings Per Share. The EPS will grow by 20.71% on average per year.
CBK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.35% yearly.
EPS Next Y9.99%
EPS Next 2Y13.19%
EPS Next 3Y15.07%
EPS Next 5Y20.71%
Revenue Next Year3.24%
Revenue Next 2Y3.76%
Revenue Next 3Y3.79%
Revenue Next 5Y4.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.75, the valuation of CBK can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CBK is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 25.20, CBK is valued rather cheaply.
A Price/Forward Earnings ratio of 7.04 indicates a rather cheap valuation of CBK.
Based on the Price/Forward Earnings ratio, CBK is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.60. CBK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.75
Fwd PE 7.04

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBK indicates a rather cheap valuation: CBK is cheaper than 93.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.9
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBK's earnings are expected to grow with 15.07% in the coming years.
PEG (NY)0.78
PEG (5Y)0.36
EPS Next 2Y13.19%
EPS Next 3Y15.07%

3

5. Dividend

5.1 Amount

CBK has a Yearly Dividend Yield of 2.62%.
Compared to an average industry Dividend Yield of 5.95, CBK's dividend is way lower than its industry peers. On top of this 88.64% of the companies listed in the same industry pay a better dividend than CBK!
CBK's Dividend Yield is comparable with the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 2.62%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

12.32% of the earnings are spent on dividend by CBK. This is a low number and sustainable payout ratio.
DP12.32%
EPS Next 2Y13.19%
EPS Next 3Y15.07%

COMMERZBANK AG

FRA:CBK (4/23/2024, 7:00:00 PM)

13.88

+0.38 (+2.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.21B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.62%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.75
Fwd PE 7.04
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.78
PEG (5Y)0.36
Profitability
Industry RankSector Rank
ROA 0.39%
ROE 6.35%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 16.15%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)73.98%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y9.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.75%
Revenue growth 3Y10.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y